During the past decade, Nephrology and Hypertension Associates PC conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nephrology and Hypertension Associates PC" #1 sponsor was "Pfizer" with 2 trials, followed by "Trevi Therapeutics" with 2 trials sponsored, "Ash Access Technology" with 1 trials sponsored, "Ineos Healthcare Limited" with 1 trials sponsored and "Vertex Pharmaceuticals Incorporated" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nephrology and Hypertension Associates PC" #1 collaborator was "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Nephrology and Hypertension Associates PC" are "Pruritus" (2 trials), "Uremic Pruritus" (2 trials), "Chronic Kidney Disease" (1 trials), "Chronic Kidney Failure" (1 trials) and "Chronic Renal Failure" (1 trials). Many other conditions were trialed in "Nephrology and Hypertension Associates PC" in a lesser frequency.

Most popular intervention types in "Nephrology and Hypertension Associates PC" are "Drug" (6 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Epoetin Hospira" (2 trials), "Placebo" (2 trials), "AAT-023 solution (Zuragen)" (1 trials), "Epogen (Amgen)" (1 trials) and "Heparin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nephrology and Hypertension Associates PC" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Nephrology and Hypertension Associates PC". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Nephrology and Hypertension Associates PC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Nephrology and Hypertension Associates PC, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".